VLA viralytics limited
Add to My Watchlist 0.00% ! $1.75

Latest clinical trial results, page-8

  1. 3rddoor
    95 Posts.
    lightbulb Created with Sketch. 16
    clock Created with Sketch.
    11/04/18
    10:36
    Post #: 32369890
    It is unfortunate that the data cutoff date was 10 March, so we are missing a month, but even so the BORR for the KEYNOTE study seems to be 13/41 or 32% and Disease control of 24/41 58%.

    It appears at mo that CAVATAK may more suited to the Yervoy trial than Keytruda, though they are different types of trial.
    VLA Price at posting: $1.69 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.